Diagnostics and specialty-provider operations

Keep sample rejection records useful for corrective action

By Vikasraj YadavPublished 5 min read

For Diagnostic/specialty operations director · Understand the problem

TL;DR — what you’ll learn

  • Preserve the authorised rejection decision and its source evidence for each sample.
  • Separate observed reason, suspected cause and corrective-action findings.
  • State whether a rate counts samples, tests, patients or recollection events.
  • Keep unknown reasons and incomplete follow-up visible instead of forcing a convenient category.

A laboratory reports eight rejected samples among 400 received samples. Another report shows eight recollections among 380 patients. Both are labelled “rejection rate”, and the manager is asked to explain why the percentages differ.

Lab sample rejection tracking should start with the unit being counted and the authorised decision. A sample-level rejection measure answers a different question from patient recollection or test cancellation. Preserve those relationships so the report supports investigation without allowing software to decide specimen suitability.

Define the numerator and population together

In an illustrative reporting period, eight of 400 received sample records have authorised rejection events. The sample-level proportion is 8 ÷ 400 = 2%. Eight recollection events divided by 380 patients is about 2.11%, but that is an event-per-patient calculation. It is not automatically the proportion of patients who required recollection: one patient might have more than one event.

Scroll horizontally to see all columns.

Define the numerator and population together
MeasureRequired numeratorRequired denominator
Sample rejection proportionDistinct rejected sample records under the defined ruleEligible received sample records in the same cohort
Patients with a recollectionDistinct patients with qualifying recollection evidenceEligible patients under the stated cohort rule
Recollection workloadQualifying recollection eventsA stated period or operating population

Clarify whether the cohort is based on receipt date, decision date or another approved definition. A sample received near month end and rejected the next morning can fall into different periods. Publish the choice and handle still-pending decisions explicitly.

Use rejection events and reason definitions already authorised by the laboratory’s qualified owners. They supply specimen suitability, decision authority and recollection procedures from the applicable laboratory process. This article compares record populations and follow-up tasks; it specifies no specimen threshold, handling instruction or reason that would authorise a rejection.

Keep the observation separate from the investigation

A rejection record should link the accession/sample identifier, authorised decision, observed reason, relevant collection/receipt references and next coordination task. The report can show a source-system reason without asserting that it proves the root cause.

For example, a reviewed observation might describe a labelling problem. The investigation could later identify a collection workflow issue, a printing fault or insufficient evidence to assign a cause. Do not rewrite the original observation to make it match a later hypothesis; record the relationship and approved conclusion.

MocDoc advertises collection and rejection features. Ask the proposed LIS to demonstrate a preliminary entry, authorised rejection, separately identified replacement and later reason correction in the intended configuration. Inspect the export and permissions. The feature description does not establish laboratory criteria or prove that the installed workflow preserves those distinctions.

Leave unknown information visible

Suppose five of the eight rejection records have reviewed reason codes and three await clarification. A report that excludes the three can make the recorded causes appear more certain than they are. Show “reason awaiting review” as an evidence state, alongside the total rejected population.

The two percentages describe their explicitly different denominators; they do not establish service improvement, causation or staff fault. Show the period, sample size, unknown reasons and collection setting with the result. Ask the laboratory quality owner to decide whether a comparison is meaningful and what investigation is warranted before using it to select corrective action.

Worked workflow

Original illustrative workflow. Follow the labelled transitions, including the exception paths.

  • A · StepAuthorised rejection event linked to sample
  • B · StepRecord observed reason and follow-up reference
  • C · DecisionReason evidence reviewed
  • D · StepKeep unknown with assigned clarification
  • E · StepInclude in defined sample cohort
  • F · StepReport denominator and incomplete records
  • G · StepQuality owner investigates pattern
  • H · StepRecord corrective action and later effectiveness review

Scroll horizontally to see all columns.

Transitions and exceptions
FromConditionNext
A: Authorised rejection event linked to sampleContinueB: Record observed reason and follow-up reference
B: Record observed reason and follow-up referenceContinueC: Reason evidence reviewed
C: Reason evidence reviewedNoD: Keep unknown with assigned clarification
C: Reason evidence reviewedYesE: Include in defined sample cohort
D: Keep unknown with assigned clarificationContinueE: Include in defined sample cohort
E: Include in defined sample cohortContinueF: Report denominator and incomplete records
F: Report denominator and incomplete recordsContinueG: Quality owner investigates pattern
G: Quality owner investigates patternContinueH: Record corrective action and later effectiveness review

Evaluate the record trail with original and replacement samples

If sample S-33 is rejected and a replacement S-34 is requested, the replacement needs its own identity linked to the original order and appropriate history. A replacement should not erase the first rejection or automatically count as another unique patient.

Test a corrected reason, repeated rejection notification, cancelled recollection and replacement received in the next reporting period. Ask the demonstrator to reproduce the numerator from underlying records and explain every exclusion. Confirm permissions and the supported data export before designing a quality dashboard.

The laboratory may initially use a reviewed exception list rather than a complex automated score. The useful acceptance condition is that each displayed measure can be reconstructed and each unresolved item has an owner. Speed of reporting cannot compensate for an unclear denominator.

A rejection report should help the quality team ask a better question about the process. It becomes dependable when observations, authorised decisions, cohort definitions and later findings stay distinct and traceable.

Next actions

  1. Agree one sample-level measure and its receipt/decision cohort with the laboratory quality owner.
  2. Reconstruct the eight-of-400 example, including unknown reasons and replacement samples.
  3. Use the LIS evaluation to test authorisation, correction history and reproducible reporting.

Continue your evaluation

Continue with the diagnostic LIS evaluation to test whether rejection, replacement and report records preserve their own identities and authorities.

Choose a diagnostic LIS using sample and result handovers

Applying this guide

The scenarios and numbers are illustrative. Confirm these provider-specific inputs before implementation:

  • Authorised laboratory professional and quality manager: Applicable current laboratory procedures and standards; no specimen thresholds or automatic acceptance decisions inferred.
  • Laboratory quality lead and reporting/statistical owner: Approved indicator definitions, exclusions and investigation/effectiveness-review method.
  • LIS owner and laboratory implementation lead: Demonstrate duplicates, corrected reasons, cross-period replacement and denominator reconstruction.

References

  • MocDoc sample management — Advertised collection/tracking topics; not clinical sample criteria, accreditation or outcome evidence.

About the author

Vikasraj Yadav writes about software and operations at NextEdge Labs. This article is an editorial workflow guide; no clinical or regulatory specialist endorsement is asserted.

Browse all healthcare guides

Topics: lab sample rejection tracking · sample rejection dashboard · laboratory rejection reasons · lab quality reporting